Celltrion
068270.KS
#829
Rank
โ‚ฌ21.18 B
Marketcap
97,31ย โ‚ฌ
Share price
-0.06%
Change (1 day)
-20.51%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): 2,83ย โ‚ฌ

According to Celltrion 's latest financial reports the company's current EPS (TTM) is 2,63ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 2,56ย โ‚ฌ a decrease over its 2021 EPS that were of 3,05ย โ‚ฌ.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)2,83ย โ‚ฌ10.5%
20222,56ย โ‚ฌ-15.84%
20213,05ย โ‚ฌ12.77%
20202,70ย โ‚ฌ70.79%
20191,58ย โ‚ฌ15.63%
20181,37ย โ‚ฌ-33.13%
20172,05ย โ‚ฌ141.17%
20160,85ย โ‚ฌ8.28%
20150,78ย โ‚ฌ11.28%
20140,70ย โ‚ฌ16.37%
20130,61ย โ‚ฌ-67.42%
20121,86ย โ‚ฌ84.22%
20111,01ย โ‚ฌ62.13%
20100,62ย โ‚ฌ80.61%
20090,34ย โ‚ฌ-559.63%
2008-0,07491ย โ‚ฌ-123.16%
20070,32ย โ‚ฌ